antihypertensive therapy

Escalating Antihypertensive Therapy in Early-Onset Severe Preeclampsia: Dynamic Marker of Maternal Risk During Expectant Management

By MedXY 09/23/2026

Escalation of antihypertensive treatment in expectant management of early-onset preeclampsia with severe features correlates with increased maternal adverse outcomes, suggesting treatment trajectory as a dynamic risk indicator.

Emergency Medicine Neurology news

Accelerating Care in Intracerebral Hemorrhage: The Impact of Mobile Stroke Units

By MedXY 07/05/2026

Mobile Stroke Units enable faster diagnosis and initiation of antihypertensive treatment in intracerebral hemorrhage, significantly reducing time to care compared with conventional EMS transportation.

Cardiology Internal Medicine news

Quadpill or Dual Therapy for hypertension? Emerging Consensus After QUARTET — What Clinicians and Patients Should Know

By MedXY 11/14/2025

Summarizes emerging expert consensus on ultra‑low‑dose quadruple antihypertensive therapy (the “quadpill”) after QUARTET and related evidence, with practical recommendations and caveats for clinical use.

Clinical Updates news OB/GYN & Women's Health

Optimizing Nifedipine GITS Dosing in Severe Preeclampsia: Daily 60 mg versus 30 mg BID – Evidence from a Randomized Controlled Trial

By MedXY 09/19/2025

This RCT compares nifedipine GITS 30 mg twice daily versus 60 mg once daily in severe preeclampsia, finding similar blood pressure control but fewer emergent treatments with twice-daily dosing, informing safer antihypertensive strategies in pregnancy.

Cardiology news Specialties

Reevaluating Antihypertensive Therapy in Frail Elderly Nursing Home Residents: Insights from the RETREAT-FRAIL Trial

By MedXY 08/30/2025

The RETREAT-FRAIL trial found no survival benefit from progressively reducing antihypertensive medications in frail nursing home residents aged ≥80 with controlled blood pressure, supporting individualized treatment strategies.